Artiva Biotherapeutics grants 288,800 inducement RSUs to 17 new employees

The Nasdaq-listed biotech said the awards were approved under its 2025 Inducement Plan and became effective July 14, 2026, with vesting spread over four years.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.